abstract |
A stable crystalline form of 4- [5-methyl-3-phenylisoxazol-4-yl] -benzenesulfonamide is disclosed. This crystalline structure, designated Form B, has advantageous handling properties and is characterized by its melting point, X-ray or other characteristics. |